Carregant...

Macitentan: entry-into-humans study with a new endothelin receptor antagonist

PURPOSE: To study the pharmacokinetics, pharmacodynamics, and tolerability of rising single doses of macitentan, an endothelin receptor antagonist, in healthy male subjects. METHODS: This double-blind, placebo-controlled study was performed in seven groups of eight healthy male subjects. Doses of 0....

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Sidharta, Patricia N., van Giersbergen, Paul L. M., Halabi, Atef, Dingemanse, Jasper
Format: Artigo
Idioma:Inglês
Publicat: Springer-Verlag 2011
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3169777/
https://ncbi.nlm.nih.gov/pubmed/21541781
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00228-011-1043-2
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!